Brian Cunniff News Today

A clinical study at the University of Vermont Cancer Center has hit a milestone as research moves into Phase 2. The trial is developing a drug that could help cancer patients.

Data presented by Dr. Dean Fennell in an oral presentation at the IASLC 2023 World Conference on Lung Cancer in SingaporeRS Oncology’s novel therapy RSO-021, a first-in-class inhibitor of the antioxidant protein PRX3, was shown to reverse many of the features associated with aggressive mesothelioma tumor growthCAMBR...

Let's take a look at the most accomplished male athlete of each and every Cape-Atlantic League high school.

Let's take a look at the most accomplished male athlete of each and every Cape-Atlantic League high school.

Let's take a look at the most accomplished male athlete of each and every Cape-Atlantic League high school.

Researchers at UVM Cancer Center have begun their first in-human clinical trial of the potentially groundbreaking new drug RSO-021.

A promising new therapy for mesothelioma and metastatic cancer, arising from laboratory investigations at the University of Vermont Cancer Center, is about to e

Let's take a look at the most accomplished male athlete of each and every Cape-Atlantic League high school.

Let's take a look at the most accomplished male athlete of each and every Cape-Atlantic League high school.

Let's take a look at the most accomplished male athlete of each and every Cape-Atlantic League high school.